The study involving 45 HBV-related HCC patients indicate that patients with HBV-HCC harboring the HBV Pre-S2 Mutant exhibit elevated PD-L1 expression compared to other HBV-HCC patients. Here, CD274 is linked to hepatocellular carcinoma.